Browsing Tag
Hellenic Institute for the Study of Sepsis
1 post
EMBRACE results prompt Sobi to engage regulators on emapalumab sepsis pathway
Sobi will advance emapalumab in IFNγ-driven sepsis after EMBRACE trial shows proof-of-concept. Find out what this pivot means for its strategy and the field.